CILOSTAZOL - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for cilostazol and what is the scope of freedom to operate?
Cilostazol
is the generic ingredient in two branded drugs marketed by Actavis Elizabeth, Apotex Inc, Aurobindo Pharma Usa, Casi Pharms Inc, Chartwell Rx, Epic Pharma Llc, Hikma, Ivax Sub Teva Pharms, Nostrum Labs Inc, Pliva Hrvatska Doo, Rising, Slate Run Pharma, Teva, and Otsuka, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are twelve drug master file entries for cilostazol. Ten suppliers are listed for this compound.
Summary for CILOSTAZOL
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 14 |
NDAs: | 15 |
Drug Master File Entries: | 12 |
Finished Product Suppliers / Packagers: | 10 |
Raw Ingredient (Bulk) Api Vendors: | 128 |
Clinical Trials: | 136 |
Patent Applications: | 6,741 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for CILOSTAZOL |
What excipients (inactive ingredients) are in CILOSTAZOL? | CILOSTAZOL excipients list |
DailyMed Link: | CILOSTAZOL at DailyMed |
Recent Clinical Trials for CILOSTAZOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Beijing Tiantan Hospital | Phase 2 |
NeuroDawn Pharmaceutical Co., Ltd. | Phase 2 |
Ain Shams University | Phase 2/Phase 3 |
Pharmacology for CILOSTAZOL
Drug Class | Phosphodiesterase 3 Inhibitor |
Mechanism of Action | Phosphodiesterase 3 Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for CILOSTAZOL
US Patents and Regulatory Information for CILOSTAZOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Slate Run Pharma | CILOSTAZOL | cilostazol | TABLET;ORAL | 077208-001 | Mar 29, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Nostrum Labs Inc | CILOSTAZOL | cilostazol | TABLET;ORAL | 077708-001 | Sep 28, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Aurobindo Pharma Usa | CILOSTAZOL | cilostazol | TABLET;ORAL | 077019-002 | Nov 23, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Slate Run Pharma | CILOSTAZOL | cilostazol | TABLET;ORAL | 077208-002 | Mar 29, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Apotex Inc | CILOSTAZOL | cilostazol | TABLET;ORAL | 077030-001 | Dec 10, 2004 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Pliva Hrvatska Doo | CILOSTAZOL | cilostazol | TABLET;ORAL | 077898-001 | Oct 29, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Epic Pharma Llc | CILOSTAZOL | cilostazol | TABLET;ORAL | 077022-002 | Mar 11, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CILOSTAZOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Otsuka | PLETAL | cilostazol | TABLET;ORAL | 020863-001 | Jan 15, 1999 | ⤷ Sign Up | ⤷ Sign Up |
Otsuka | PLETAL | cilostazol | TABLET;ORAL | 020863-002 | Jan 15, 1999 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.